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Positive affective state is the subjective experience of positive emotions and is linked to well-being 
and resilience. Animal welfare now advocates for the promotion of positive affective experiences in 
addition to reducing negative experiences. Positive affective state in animals can be determined 
through judgement bias but this is a lengthy procedure inefficient for industry. A rapid non-invasive 
biomarker to assess positive well-being of animals is essential to inform ethical industry practice.  
 
MicroRNA (miRNA) are stable molecules found in most mammalian cell types which post-
transcriptionally regulate target genes altering biological mechanisms. MiRNA expression is altered 
by changes in environment. There has been much research on identifying miRNA as biomarkers for 
depression, but there is limited knowledge regarding their use as biomarkers of positive affective 
state. The aim of this study was to identify miRNA which are differentially expressed over time in 
oppositely valenced affective states created through environmental manipulation.     
 
Housing environment of rats was used to create change in valence of affective state which was 
validated by judgement bias test. MiRNA extracted from blood and amygdala tissue were analysed 
for differential expression between housing groups at Day 3 and Day 10. 
 
Metabolic cages created significant negative bias compared to home cages at Day 10 (p=.024). 
Metabolic cage housing associated with negative bias drove miRNA expression changes in blood 
with multiple miRNA significantly upregulated. Of these, miR-193, miR-142 and miR-326 regulate 
pathways associated with physiology, immune response, and the dopaminergic system informing 
mechanisms of well-being with potential as biomarkers.   
 
 




Introduction   
 
Attitudes to animal welfare are dynamically challenging industry’s ability to maintain their social 
licence to farm livestock. Treatment of animals has progressively become an important issue 
guiding practice of ethical agriculture and welfare of laboratory animals1. An older definition of 
animal welfare encompasses animals’ access to food, water and appropriate housing while being 
free of injury or disease and enabling innate behaviours2. More recently this definition has 
expanded to include the promotion of positive affective experiences for the animal rather than 
solely reducing negative states3. Resilience4 and well-being5 are linked to subjective experiences of 
positive emotional states like joy and enthusiasm. Depression and anxiety in humans are associated 
with negative or less positive affective states6. Similar phenotypes are found in animals who 
experience harsh environments7 and handling techniques8. Emotions launch adaptive responses of 
cognition and action allowing for integrated physiological reactions to  the external environment9. 
Activated physiological systems, such as the immune system, have bidirectional association with 
affective states10 providing potential avenues to measure positive experiences in animals.  
 
Arousal vs valence of affective state  
Perception of external sensory information is processed and bound to physiological reactions11. 
How we sense and comprehend the environment around us is reflected in our emotional response. 
Emotional arousal is a measure of the intensity of an affective state, observed through behavioural 
and physiological indices such as levels of glucocorticoids12.  However, these measures do not 
determine valence, whether the experience is felt as positive or negative. For example, heart rate 
may increase when encountering a predator or a sexual partner; situations presumably evoking two 
oppositely valenced emotions13. Although arousal provides some measure of affective state, valence 
of affective state determines the impact, positive or negative, on the animal with implications for 




welfare13. Valence of emotion influences bias in cognitive processing including attention, memory 
and judgement14.   
 
Judgement bias test 
Affective state at any point in time is comprised of trait affect, environment, and previous 
experience13. Affective state influences cognitive processing of information creating bias in 
decision-making which reflects the underlying affective state whilst cognitive perception of stimuli 
shapes emotional responses13. Bias in cognitive processing is an attested indicator of affective state 
and emotional valence, and bias in animals is discerned using a judgment bias test13. The judgement 
bias test involves combined facilitation of the animal’s sensory, cognitive and movement systems. 
The animal senses the environment, evaluates stimuli from memory of associations previously 
made, selects a response and performs an action13. The active choice judgement bias test determines 
relative affective state through the interpretation and subsequent action the animal makes to an 
ambiguous stimulus13. Actions associated with expectation of a positive or more valued event 
(optimistic choice) in response to an ambiguous stimulus suppose a positive affective state while 
actions associated with an expectation of a negative event or lower reward (pessimistic choice) 
suppose a negative affective state13. 
 
Environment manipulates affective state 
There is much evidence that cognitive processing of animals is biased by environmental conditions 
and more optimistic choices, expecting a positive event, are made when in an enriched 
environment15, 16. Barker et al. showed that the environmental change from housing conditions 
altered the number of optimistic choices made by rats in a judgement bias test17. Housing in 
metabolic cages induces behavioural changes in rats inferring a negative environment18. Male rats 
housed alone in  metabolic cages showed a significant decrease in the number of optimistic 
decisions made in response to an ambiguous stimulus17. Environmental enrichment induced 




optimistic cognitive bias in rats when transferred from an unenriched cage suggesting a more 
positively valenced affective state was created15. 
 
The role of the Amygdala in affective state 
The underlying biological mechanisms of affective states are not yet understood, however certain 
brain regions have been identified. The amygdala is activated in response to stimuli which elicit 
emotions, both negative and positive19. Activation of the amygdala, part of the emotion regulatory 
limbic region, has been linked to reward-seeking behaviour20. The transcriptome of the amygdala 
has not been well studied to date and may reveal insights into cellular and molecular processes of 
affective state.   
 
MiRNA and positive affective state 
MiRNA are small non-coding RNA (20–22 nucleotides) which regulate gene expression post-
transcriptionally. Whilst miRNA are particularly prevalent in brain sites, they can be detected in 
components of the blood21 where they reflect physiological conditions22.  MiRNA are 
downregulated or upregulated rapidly in response to changes in environment which alter the 
affective state of  animals23. MiRNA preserve their stability in tissue samples and can be readily 
extracted and evaluated, providing a practical tool for a clinical biomarker22. MiRNA have 
previously been studied for their association with depression and other psychiatric disorders24. 
However, there is limited literature on the association of miRNA with positive affective state. 
 
Two studies have identified miRNA associated with positive affective state. Firstly, Wingo et al, 25 
identified a single nucleotide polymorphism (SNP), rs322931, in humans which predicted 
expression of miR-181 in positive affective state. MiR-181a in the nucleus accumbens of rats 
influences synaptic plasticity26 and miR-181a/b helps regulate T-cell receptor sensitivity in mice27 
thus connecting miRNA expression within reward centres of the brain and the immune system to 




positive affective state. The second study identified miR-132 expression in the basolateral amygdala 
(BLA) in mice as having a role in learned safety, through modulating expression of genes which 
determine neural excitability and synaptic plasticity28.  Learned safety relates to positive affective 
state and a reduction of depression-like behaviour in mice through identifying experiences of 
security29.   
 
Objective 
The judgement bias test has been validated as a tool for measuring valence of affective state in 
animals30. However, training in the judgement bias paradigm takes days to complete rendering it 
impractical for use in the agricultural field. Combinations of miRNA associated with positive 
affective state may be useful as biomarkers facilitating an objective welfare assessment tool via a 
quick, relatively non-invasive sampling method. The objective of this project was to firstly create 
two differently valenced affective states in rats through environmental manipulation, determined 
through a judgement bias test. Rats are used as a representative species with the assumption that 
findings will translate across species. The second aim was to explore differential expression of 
miRNA between the validated affective states between two timepoints and to investigate correlation 
of expression between amygdala and blood tissue. The hypothesis of my study is that environmental 
manipulation of affective state, as determined through a judgement bias test, will induce temporally 
relative differential expression of miRNA which will be correlated between blood and brain tissue 











Materials and Methods      
 
Animals 
The study was granted ethics approval (#33110(v2)) by the University of Adelaide Animal Ethics 
Committee in accordance with the Australian Code for the Care and Use of Animals for Scientific 
Purposes31 and the Animal Welfare Act (SA)32. 
 
Animals were sourced from a barrier maintained, specific pathogen free production facility 
(University of Adelaide, Laboratory Animal Services, Adelaide, Australia). Rats were male (n=42) 
Sprague-Dawley outbred strain (Hsd:SD) which arrived at 4-weeks of age, at different intervals, 
and were initially housed in groups of 6 into Individual Ventilated Cages (IVC). Animals were 
habituated in the IVC home cage (Tecniplast Double-Decker IVCs, 4620 x 4030mm) for a 
minimum of 5 days. Animals had ad libitum access to a food hopper containing dry pellets (Teklad 
Global Soy Protein-Free Extruded Rodent Diet), and two water drippers containing reverse osmosis 
water during their training and experimental phases. Animal weights were recorded daily. 
 
Experimental design   
The experimental design to determine valence of affective state was based on a shortened protocol 
for the judgement bias test proposed by Brydges & Hall30. The procedure is explained in brief in 
Table 1 with testing apparatus shown in figure 1. Training involved associating a more highly 
valued reward, chocolate, with fine grade sandpaper and the lesser reward, a cheerio, with coarse 
grade sandpaper. During the judgement bias test an intermediate grade sandpaper was used as the 
ambiguous stimulus and responses documented.  
 




Table 1. Schedule for shortened judgement bias paradigm 
  Judgement bias training schedule 
Habituation Animal placed in apparatus for 5 mins, no rewards, no tactile stimuli 
Phase 1 training Free access to both compartments which contain a cheerio or chocolate 
Phase 2 training Exploring tactile association to rewards and encouraging foraging 
Phase 3 training Reinforcing association of a tactile stimulus to a reward 
Phase 4 probe trial Baseline trial for all animals – randomized ambiguous tactile stimulus 
Separation Animals randomly moved to treatment cages  
Phase 4 probe trial Randomized trials with ambiguous tactile stimulus at Days 3 and 10 
Primary outcomes to 
measure 
Optimistic, pessimistic or No choice 
Latency to make a choice, max 5 mins 
 
 
Figure 1: Schematic of testing apparatus utilised in judgement bias test. (A) sandpaper as stimulus, 
(B) & (C) reward bowls. (Diagram reproduced from Cutler, 201933unpublished).  
  
Animals were tested for baseline data where the ambiguous stimulus was first encountered.  
Animals were then randomly separated into two housing conditions: isolated in a metabolic cage 
with metal grid floor and no shelter (220 mm in diameter × 120 mm tall) or remaining in IVC.   
Animals were kept in housing conditions for 3 day or 10 day durations (figure 2). At the end of 




these timepoints animals were again tested in the judgement bias paradigm, followed by humane 







Figure 2.  Rats were randomly allocated between metabolic cage and IVC housing and further 
distributed into temporal groups (3 or 10 days).  Cognitive biases validated affective state through 
judgement bias test (n=12 per group with n=6 for Day 10 IVC group).  
 
Tissue collection and storage  
Blood was taken by cardiac puncture from rats immediately following euthanasia, put into 
RNAprotect® Animal Blood Tubes (QIAGEN) as per manufacturer instructions and stored at          
-80°C. Rat brains were extracted, cut with scalpel into forebrain, middle and hindbrain using a brain 
matrix as guide, then stored separately in RNAlater™ Stabilisation Solution (ThermoFisher) at         
-80°C. Judgement bias testing and tissue collection undertaken by Cutler33 in 2019. 
 
Tissue sample size 
A sample size of 5 was used per group for miRNA extraction. Tissue was randomly assigned from 
each housing condition (metabolic, IVC), and each timepoint (Day3, Day 10) using the free online 
website https://miniwebtool.com/random-picker/. This gave a total of 20 samples of brain tissue and 
20 samples of blood tissue. 




Microdissection     
The frozen brain tissue containing the amygdala (n=20) were thawed on ice. Rat brain identity 
numbers were randomised as to which side, left or right amygdala, would be utilised: 11 samples of 
left and 9 samples of right amygdala. The 2004 Allen Institute for Brain Science, Allen Mouse 
Brain Atlas34 was used as a guide with a dissecting microscope utilised to extract the amygdala. 
Amygdala samples were separately homogenized using a Kimble ® PELLET PESTLE® Cordless 
Motor and added to 1-Thioglycerol/Homogenization solution from the Maxwell® 16 miRNA 
Tissue Kit (Promega) according to manufacturer’s protocol and stored overnight at -80°C. 
 
MiRNA Extraction    
Amygdala miRNA was extracted over two days:10 samples per day. The frozen homogenised 
amygdala were thawed on ice.  MiRNA extraction from the amygdala was undertaken according to 
manufacturer’s protocol using the Maxwell® 16 miRNA Tissue Kit (Promega) with the Maxwell® 
16 Instrument (Cat.# AS2000) updated to firmware version 4.98. 
MiRNA extraction of blood tissue was undertaken using the Qiagen RNeasy® Protect Animal 
Blood Kit according to manufacturer’s protocol. 20μl of elution buffer was added per sample to 
obtain final miRNA elute. 
Quantification of miRNA was verified using the BioTek SynergyMX multi-mode microplate 
reader. The miRNA elutes were then stored at -80°C. 
The required concentration of miRNA of 500ng/8ul per sample was prepared by adding nuclease 
free water and delivered to the Australian Genome Research Facility (ARGF) Cancer Genomics 
Facility, Centre for Cancer Biology, Adelaide, Australia for gene expression microarray analysis. 
 
MiRNA microarray analysis   
The miRNA expression profiles were analysed by ARGF Cancer Genomics Facility, Adelaide, 
Australia using the Affymetrix® GeneChip miRNA 4.0 array for multi species.  MiRNA from brain 




and blood tissue was biotin-labelled using the FlashTagTM Biotin HSR RNA Labeling Kit for 
GeneChip miRNA Arrays (Thermo Fisher Scientific) after Poly (A) tailing. Labelled miRNA 
samples were hybridised to GeneChip miRNA v4.0 arrays and incubated in a GeneChip® 
Hybridization Oven 645 for 16 hours at 48°C. Chips were washed and stained using a Affymetrix® 
Genechip Fluidics Station 450 and then scanned with an Affymetrix® GCS 3000 7G scanner. CEL 
files of signal values were generated using Affymetrix® GeneChip™ Command Console software.  
 
Statistical analysis  
Choice response of rats to ambiguous stimuli: optimistic, pessimistic and No choice, were analysed 
using Pearson’s Chi-square test. Latency data was analysed using the Mann-Whitney test as data 
was found nonparametric by the Shapiro-Wilk test. Graph Pad Prism 8 was used to analyse choice 
and latency data. Using box-plots to identify upper and lower limits of 2 standard deviations (SD), 
outliers were removed from the baseline and Day 10 latency data before analysis35.  Due to low 
number and differing sample size for the Day 10 latency data, a corrected effect size was calculated 
using Hedges’ g.  Weight gain was analysed as percentage of baseline weight using Mann-Whitney 
test. 
 
The raw data CEL files were imported into the Transcriptome Analysis Console (TAC) 4.0 software 
downloaded from the ThermoFischer website. Data was normalised and analysed for rat by 
selecting miRNA level RMA+DABG-Rat analysis. The analyses conducted in TAC were one-way 
ANOVA with Bayesian correction. Probe sets were considered as biologically significant if the fold 









Results   
 
Judgement bias test choice responses 
There was a significant difference in the percentage of optimistic choices made at Day 10              
(χ² (2, n=6-12) = 7.4, p= .024) between IVC and metabolic cage groups (figure.3). There was no 
significant difference in judgment bias choice response between grouped animals at baseline before 
allocation to the two housing conditions (χ² (2, n=42) = 0.17, p= .92). Animals at day 3 showed no 
significant difference in judgment bias choice response between IVC and metabolic cage groups    
(χ² (2, n=12-12) = 5.6, p= .061). 
 
 Figure 3. A higher percentage of optimistic choice (per group) was made in the IVC compared to 
metabolic cages at Day 10. Asterisk denotes significance (p=.024). Choice data analysed using a 








Judgement bias test latency 
No significance was found in latency of decision time between grouped animals at baseline before 
allocation to housing conditions after outliers over 2 SD were removed (p=.063). At day 3 no 
significance was found in latency of decision time between animals in metabolic cage compared to 
animals in IVC group (p=.074). After removing an outlier, a large effect size was found in latency 
between rats (n=8) housed in metabolic cages (M=41.4, SD=39) compared to rats (n=3) in IVC 
(M=5.7, SD=0.29, 95% CI[-16, 87], Hedges’ g= 1.1. Reduced data samples due to technical failure.    







Figure 4. No significance found for latency in decision time between housing conditions.  However, 
variability between individuals increased over time within the metabolic cage group. Data presented 
as median with IQR. (Sample sizes varied due to technical failure). 
 
Weight gain 
The difference in median percentage weight gain of animals significantly increased between 
housing conditions at Day 10 (p=.033).  Inter-individual variability in weight gain increased in 
animals from metabolic cages becoming more pronouced at Day 10 (figure 5). 





Figure 5. Inter-individual varaition in weight gain was more pronounced in metabolic cage group 
(MET). By Day 10 the gap in percentage weight gain of the groups showed significance (p=.033) 
between housing conditions.   
 
MiRNA expression 
Blood of rats from metabolic cage group showed expression of 10 miRNA probes were 
significantly upregulated (FDR<0.1) in Day 10 animals compared to Day 3 animals (Table 2). 
These 10 miRNA probes related to seven miRNA families: miR-25, miR-142, miR-193, miR-326, 
miR-328, miR-331 and let-7 with one unknown association (Table 3).  Expression of these blood 
miRNA show inter-individual variation from Day 3 and Day 10 animals in metabolic cages (figure 
6). The expression of several blood miRNA reveal greater sensitivity to housing condition and 
duration as shown in figure 7. In addition, blood levels of rno-miR-190a-3p in the metabolic cage 
group, although not significant (FDR=0.38), showed a downregulation with FC=16, p=.02 in Day 









Table 2. Blood miRNA differentially expressed between housing conditions and timepoints. 
Blood samples  Comparing MiRNA differential expression 
FC>2, FDR<0.1 
Metabolic cage Day 3/Day 10 10 miRNA    
IVC Day 3/Day 10 Nil  
Day 3 Metabolic cage/IVC Nil 
Day 10 Metabolic cage/IVC Nil 
  (FC: fold change; FDR: False discovery rate)      
 
 
Table 3. Upregulation of blood miRNA from metabolic cage animals at Day 10 compared to Day 3. 
 miR family miRbase iD FC p-value FDR 
miR-326 rno-miR-326-5p 5.3 0.0003 0.078 
miR-331 rno-miR-331-3p 4.5 0.0001 0.068 
let-7 rno-let-7d-3p 3.5 0.0003 0.078 
miR-193 rno-miR-193-3p 3.1 0.0005 0.086 
miR-328 rno-miR-328a-3p 2.7 8.40E-05 0.068 
miR-326 rno-miR-326-3p 2.5 0.001 0.098 
miR-25 rno-miR-92b-3p 2.3 0.0005 0.086 
let-7 rno-let-7a-5p 2.1 0.0007 0.086 
miR-142 rno-miR-142-5p 2.0 0.0007 0.086 



















Figure 6. Inter-individual variation shown in heat map. Blood miRNA expression of rats from 
metabolic cages were differentially expressed between Day 3 and Day 10 animals. Day 3 animals 














Figure 7.  Sensitivity to changes in housing conditions and duration is greater for several miRNA. 
Blood miRNA expression shows large variability between and within treatment groups. Graph 
generated through R by Kelly Ren. (10IVC, 10MET: 10 day, 3IVC, 3MET: 3 day) 
 
 
A search of PubMed literature starting with the last 5 years revealed expression of miR-193-3p, 
miR-142-5p and miR-326-5p are involved with regulation of the dopaminergic system. These three, 
in addition to miR-190a-3p, are also potentially facilitating stress response pathways relating to 
physiology and the immune system (Table 4).   





Table 4.  Metabolic cage driven blood miRNA are associated with functions relating to stress. 
MiRNA Expression Associated biological functions Targets  References 
miR-193-3p ↑ dysfunction of tyrosine hydroxylase, insufficiency of dopamine 
synthesis 
ALDH2 36 
miR-142-5p ↑ dopaminergic neurotransmission SIRT1 37 
 ↑ impairment of spatial memory, emotion-related behaviour Npas4 38 
 ↑ critical regulator of dendritic cell homeostasis  39 
 ↑ immunometabolic regulator of intracellular  cAMP regulatory T cells 40 
 ↑ pathogenesis of autoimmune neuroinflammation  Tcell differentiation 41 
  cardiac muscle cell survival cytokine receptor gp130 42 
  angiogenesis vessel tone 43 
 ↑ apoptosis in human macrophages with link to atherosclerosis TGF-β2 44 
 ↑ induced in fever IL-6, IL6ST, TLR2, PGE2, TNF 45 
miR-326-5p ↑ increase autophagy of dopaminergic neurons via JNK signalling 
pathway 
XBP1 46 
 ↑ reduced dopamine receptor D2 mRNA and receptor synthesis  47 
 ↑ promote T helper 17 (TH-17) cell differentiation Ets-1 48 
 ↑ immune response, down-regulation of pro-inflammatory 
cytokines 
TLR4 49 
 ↑ endoplasmic reticulum stress, mitochondrial fission, apoptosis PKM2 50 
miR-190a-3p ↓ regulates insulin sensitivity IGF1 51, 52 
 




There was no differential expression of miRNA identified through TAC software in the amygdala 
between housing conditions or between timepoints (Table 5). Correlation of miRNA differential 
expression between the amygdala and blood tissue could not be identified. 
Table 5. Amygdala miRNA differentially expressed between housing conditions and timepoints. 
Amygdala samples  Comparing MiRNA differential expression 
FC>2, FDR<0.1 
Metabolic cage Day 3/Day 10 Nil    
IVC Day 3/Day 10 Nil  
Day 3 Metabolic cage/IVC Nil 
Day 10 Metabolic cage/IVC Nil 
  (FC: fold change; FDR: False discovery rate)      
 
 
Discussion   
 
The negative environment of the metabolic cage18 by Day 10 induced a  difference in the 
informational processing of rats demonstrating negative bias as determined through the active 
choice judgement bias test. This supposes the affective state of these rats was negatively valenced.  
In addition, rats in metabolic cages gained less weight. The stress response induced from a negative 
environment activates the hypothalamic–pituitary–adrenal (HPA) axis releasing stress hormones 
which mobilise energy from adipose tissue and sustain the immune system53.  Rats in the metabolic 
cages may have undergone physiological mechanisms converting lipid storage to energy to maintain 
the stress response, hence gaining less weight. Energy demand from the brain increases during 
times of stress so while metabolic caged rats are limited in movement, the cognitive processing 
involved may be energy intensive54. 
 
The amygdala is crucial for stimulus–reward learning55 and processing of external stimuli19. The 
amygdala extracts information with biological relevance from the environment19 and moulds 




ensuing behavioural responses56. Although my study found no  difference in amygdala miRNA 
expression between treatment groups, Haramati et al.57 found differential expression of miRNA in 
the amygdala of adult mice exposed to acute stress compared to controls. The region of the 
amygdala includes multiple nuclei with functional segregation. Evidence has shown the BLA 
structurally connects with areas of sensory information, whereas the central nucleus of the 
amygdala signals the endocrine, autonomic, and somatomotor pathways58. This variation in function 
of the amygdala nuclei may have confounded results in discerning patterns of miRNA expression; 
miRNA have cell type and tissue specificity59   
 
In parallel with behavioural changes at Day 10, blood expression of multiple miRNA from 
metabolic caged animals were upregulated in day 10 animals compared to day 3 animals suggesting 
the negative experience had temporally changed genetic functioning of systems manipulating 
cognitive processing of the animals. These miRNA with altered expression, through the target genes 
they post-transcriptionally regulate, may reveal pathways linked to affective state.  
 
Exosome mediated transport of miRNA suggest a mechanism of cell-to-cell communication 
between the brain and the periphery24. Exosomes are membrane vesicles (50–90 nm) of endocytic 
origin and were found to contain miRNA expressed at higher levels than in cells60.  Exosomes have 
potential as mechanisms of communication through the systemic circulation in a way resembling 
hormones, allowing miRNA regulatory communication between mammalian cells; exosomes 
contain molecular components linked to the specificity of their original cells61. There is potential 
that the miRNA found upregulated in the blood of animals in the metabolic cages comprise a 
miRNA signature, communicating neurophysiological activity influencing behaviour. Identifying 
circulating exosomal miRNA regulating gene expression of mechanisms associated with brain 
regions involved in positive affective state could progress research towards a biomarker for animal 
welfare.  




The inter-individual variability within groups (figure 6) shows individuals have their own miRNA 
expression levels. This variability increases (figure 7) with several blood miRNA expression 
showing greater reactivity to different conditions. Increased variability in blood miRNA expression 
in response to altered conditions occurred with miR-326-5p, miR-193-3p and miR-142-5p (figure7). 
Patterns of expression for particularly sensitive miRNA could predict resilience or well-being in an 
individual animal; combinations of these could identify a miRNA signature, suggesting epigenetic 
regulation as an individual’s adaptive response to environment. 
 
Dysfunction of the dopaminergic system has been linked to the stress response and the HPA axis, 
limiting the ability to select and process significant environmental stimuli62; dopamine 
neurotransmission is connected to motivated action towards reward62. A miR-142-5p target gene is 
involved with stress-induced brain dysfunction and decreases in brain-derived neurotrophic factor 
(BDNF)63 and miR-326 overexpression has been linked to reduced dopamine connectivity. Studies 
reveal circulating miR-193 affect schizophrenia64 and Parkinson’s disease65, and may regulate the 
amyloid precursor protein in Alzheimer’s disease66 . 
 
Dysregulation of the immune system has been linked to pathophysiology. MiR-326 is associated 
with TH-17cells which  secrete interleukin-17 (IL-17), implicated in neurological diseases 
associated with cognitive impairment and IL-17 was shown to disrupt the blood brain barrier 
integrity67. MiR-326 are highly expressed in neurons68 and through overexpression may form a 
pathway where the brain regulates the stress adaptation response. MiR-142 inhibits the cytokine 
signalling mechanism42, is induced in fever45, and is a potential biomarker for acute myocardial 
infarction69.  
 
Overexpression of miR-326 stresses physiological pathways impairing glycolysis with implications 
for energy availability50. The downregulated miR-190a found in my study targets insulin-like 




growth factor 1(IGF1); higher levels of IGF1 are related to depression and anxiety and could be a 
protective mechanism against impaired neurogenesis resulting from a stress response70. 
 
Limitations of the study 
Chen et al.71 suggests that miRNA expressed in the medial pre-frontal cortex (mPFC) rather than 
the BLA are important indicators of resilience or vulnerability to stress. The pre-frontal cortex 
(PFC) is the site of executive function, influencing behavioural impacts of amygdala activation72. 
PFC neurons combine associations between previous experience, voluntary actions, and reward 
value73.  The PFC may be involved in a mechanism inhibiting dopamine output in the nucleus 
accumbens thereby affecting goal-directed behaviour and amygdala-mediated stimulus-reward 
association72. MiRNA from the PFC may show greater differential expression in accordance with 
differing behaviours that arise from alteration in information processing. Although the amygdala 
provides emotional processing of  perceptions from the external sensory environment, the PFC, 
downstream of the amygdala, is a potential region of miRNA expression change; regulating genes 
to enable functions evolutionarily preserved for an adaptive response.   
 
A difference in judgement bias was identified at Day 10 between the two housing conditions, 
however no difference was found in MiRNA expression.  Possibly, miRNA expression is too 
specific to the individual to act as a biomarker of affective state. However, including baseline data 
of miRNA expression or other timepoints may have revealed differences. MiRNA respond rapidly 
to environment; a study by Lecchi et al.23 detected changes in miRNA expression in turkeys after 
two hours of environmental stress. The judgement bias test itself may provide a novel environment 
for rats housed in the metabolic cage but increase stress for those taken from their home cage to a 
new environment74, reducing any differences in miRNA expression immediately before euthanasia. 
Another concern is the use of the IVC as the alternative to the metabolic cage which may have 
created an insufficiently positive environment for distinguishing mechanisms regulated by miRNA. 




The sample size may have been too small and inter-individual innate differences of rats, such as 
dominance traits, may have confounded results. A non-dominant rat may experience relief housed 
in a metabolic cage away from dominant rats. Also, animals had ad libitum access to food and if 
recently satiated would have less appetitive motivation to seek out food rewards in the test, resulting 
in increased latency or ‘No choice’ responses recorded in the allocated time. 
 
Future directions 
Multiple miRNA in blood upregulated temporally in response to metabolic cage housing. Biological 
mechanisms indicated by target genes of these miRNA included pathways of physiology, the 
immune system and the dopaminergic system which have identified associations with stress 
response. Further study could quantify these identified miRNA and target genes by using real-time 
polymerase chain reaction analysis and western blot in a replicated experiment adding measures of  
stress response such as glucocorticoid and BDNF.    
 
Conclusion 
Resilience may come from a genetic predisposition or a learned behaviour, halting progression of 
stress responses (an initial adaptive behaviour) from entering a negative downward spiral. Although 
no correlation between amygdala and blood miRNA was identified in this study at the chosen 
timepoints, the blood miRNA found to be differentially expressed between timepoints in the 
metabolic cage group may identify physiological markers relating to resilience to an external 
environmental stressor. These circulating miRNA may be initial candidates for exploration of a 
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